Stay updated on Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.8%
    Check dated 2026-11-15T14:54:05.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The study record is displayed with its recruiting status, treatment cohorts, eligibility criteria, study contacts and locations, and outcome measures. The previous 403 error and NIH transition notice are no longer shown.
    Difference
    59%
    Check dated 2026-11-08T14:42:40.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2, while the study record remains unavailable behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T15:52:55.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces updates to NIH websites and explains that some content may use “Super Intelligence” instead of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T16:33:16.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page footer now shows revision v3.7.2 instead of v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:11:15.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-11T22:17:31.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page.